Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

  1. Olivares-Hernández, A.
  2. Figuero-Pérez, L.
  3. Terán-Brage, E.
  4. López-Gutiérrez, Á.
  5. Velasco, Á.T.
  6. Sarmiento, R.G.
  7. Cruz-Hernández, J.J.
  8. Miramontes-González, J.P.
Aldizkaria:
Journal of Clinical Medicine

ISSN: 2077-0383

Argitalpen urtea: 2021

Alea: 10

Zenbakia: 9

Mota: Berrikuspena

DOI: 10.3390/JCM10091919 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak